Ostin Technology Group Co., Ltd. (OST)
Market Closed
16 Dec, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
1. 70
0
0%
$
8.98M Market Cap
- P/E Ratio
0% Div Yield
57,054 Volume
0 Eps
$ 1.7
Previous Close Day Range
1.7 1.7
Year Range
1.35 235
Want to track OST and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 39 days
Why Is Pediatric-Cancer Focused OS Therapies Stock Trading Higher On Wednesday?
On Wednesday, OS Therapies, Inc. OSTX revealed data from a Phase 2b trial of OST-HER2 (OST31-164), a HER2-targeted immunotherapy candidate in the rare pediatric-designated indication of prevention of recurrent, fully resected, lung metastatic osteosarcoma, a rare, cancerous bone tumor that develops in bone-forming cells.
Benzinga | 11 months ago
